Safety of intravenous and subcutaneous belimumab in Japanese patients with systemic lupus erythematosus: Final analysis of data from an all-case post-marketing surveillance study
Nami Okamoto, Takao Fujii, Tatsuya Atsumi, Asami Abe et autres
0 citationsModern Rheumatology